Lanoteplase

Lanoteplase

Download Bissoy App to talk Doctor online

Uses

Investigated for use/treatment in myocardial infarction.

Download Bissoy App to talk Doctor online

How Lanoteplase works

Lanoteplase is a second generation derivative of alteplase, and a third generation recombinant plasminogen activator made from a deletion and point mutant of tissue type-plasminogen activator (t-PA). Lanoteplase has a longer half life than alteplase. Lanoteplase is a serine protease that binds to fibrin in a thrombus (blood clot)and cleaves the Arg-Val bond in plasminogen, producing active plasmin. Plasmin is an enzyme that degrades plasma proteins such as fibrin clots to clear blocked blood vessels that cause myocardial infarction (heart attack) or stroke.

Lanoteplase

Trade Name Lanoteplase
Generic Lanoteplase
Lanoteplase Other Names Lanoteplase
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: August 5, 2021 at 12:40 pm

Structure

Lanoteplase
Lanoteplase Structure
Download Bissoy App to talk Doctor online
Download Bissoy App to talk Doctor online
Download Bissoy App to talk Doctor online
Download Bissoy App to talk Doctor online
Download Bissoy App to talk Doctor online
Download Bissoy App to talk Doctor online

Innovators Monograph

You find simplified version here Lanoteplase